 Nonalcoholic steatohepatitis or NASH is a common, often silent liver disease which affects about 2-5 of Americans. NASH is strongly associated with the metabolic syndrome, diabetes type-2 and obesity and can lead to cirrhosis, HCC, liver transplantation or death.This clinical trial has been designed to assess the safety of short term oral administration of Hoodia to patients with NASH. 